| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |